- Added to Email Alerts
Psoriatic Arthritis
Latest News View All
-
EULAR 2022Treat-to-Target With Tapering Proves Effective in PsA, AxSpA
-
AlertFDA Approves Risankizumab (Skyrizi) for Crohn’s Disease
-
EULAR 2022Bimekizumab Calms Psoriatic Arthritis in Phase 3 'BE' Trials
-
EULAR 2022Deucravacitinib and Orelabrutinib Perform Well in Lupus Trials
-
EULAR 2022Izokibep Improves Multiple PsA Symptoms in Phase 2 Study
-
BSR 2022Risk Factors for COVID Death Studied in U.K. Arthritis Patients
-
CARRA 2022Prior Authorizations Delay TNF Inhibitors for Children With JIA
-
AAD 2022Dermatology Residency Focuses on Rural Placement of Graduates
Perspective View All
Journal Articles View All
-
Androgen Receptor Inhibitor Therapies in Prostate Cancer
-
Body Surface Area Affected by Psoriasis and PsA Risk
-
Safety of IV Golimumab in RA, PsA, and AS
-
Drug Dosing in Hospitalized Obese Patients With COVID-19
-
Response Time for Outcomes in Psoriatic Arthritis Treatment
-
Predictive Diagnostic Criteria for Psoriasis in Children